Last ¥296.00 JPY
Change Today -1.00 / -0.34%
Volume 8.0K
7702 On Other Exchanges
As of 9:50 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

jms co ltd (7702) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/24/13 - ¥346.00
52 Week Low
02/4/14 - ¥279.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for JMS CO LTD (7702)

Related News

No related news articles were found.

jms co ltd (7702) Related Businessweek News

No Related Businessweek News Found

jms co ltd (7702) Details

JMS Co., Ltd. manufactures, sells, exports, and imports medical equipment and pharmaceuticals in Japan and internationally. The company offers infusion and transfusion sets, infusion sets with needleless access port, disposable needles and syringes, safety scalp vein sets, safety venous indwelling catheters, extension tubes, oral/enteral nutrition systems, infusion pumps, syringe pumps, and semisolid nutrition feeding devices for infusion and transfusion therapy. It also provides general medical supplies, including latex surgeon’s gloves and examination gloves, plastic gloves, treatment sheets, surgical gowns, masks and caps, drainage bags, and surgical tapes. In addition, the company offers central dialysate delivery systems, hemodialysis machines, AV fistula needles, safety AV fistula needles, AV fistula needles, hemodialysis blood tubing sets, dialyzer, prefilled syringes, hemodialysis kits, single patient dialysis machines, dialysis solution for CAPD, and automatic peritoneal dialysis machines for hemodialysis and peritoneal dialysis. Further, it provides cardiovascular therapy products, such as cardiopulmonary equipments, membrane oxygenator, heat exchangers, pacemakers, micro catheters, and cardiopulmonary blood tubing sets. JMS Co., Ltd. was founded in 1965 and is headquartered in Hiroshima, Japan.

7,144 Employees
Last Reported Date: 06/26/14
Founded in 1965

jms co ltd (7702) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jms co ltd (7702) Key Developments

JMS Co., Ltd., Annual General Meeting, Jun 25, 2014

JMS Co., Ltd., Annual General Meeting, Jun 25, 2014.

JMS Co., Ltd. Announces Consolidated Earnings Results for the Year Ended March 31, 2014; Provides Dividend Guidance for the second quarter Year Ending March 31, 2015; Provides Earnings Guidance for the Half Year Ending September 30, 2014 and Full Year Ending March 31, 2015; Announces Year End Dividend, Payable on June 26, 2014

JMS Co. announced consolidated earnings results for the year ended March 31, 2014. For the year, the company reported net income of JPY 207 million or JPY 4.25 net income per share on net sales of JPY 53,860 million compared to net income of JPY 1,277 million or JPY 29.41 net income per share on net sales of JPY 49,068 million for the prior year. Operating and ordinary income were JPY 900 million and JPY 1,187 million respectively against JPY 1,594 million and JPY 1,879 million of prior year. Income before income taxes and minority interests was JPY 981 million against JPY 1,829 million of prior year. Net cash provided by operating activities was JPY 1,206 million against JPY 2,545 million of prior year. Purchase of property, plant and equipment amounted to JPY 4,551 million against JPY 3,177 million of prior year. Purchase of intangible assets amounted to JPY 169 million against JPY 120 million of prior year. The company provided dividend guidance for the year ending March 31, 2015. The company forecasts second quarter and year end dividend of JPY 4.00 each per share and total of JPY 8.00 per share. The company announced year end dividend of JPY 4.00 per share to be paid on June 26, 2014 against the same paid a year earlier. The company provided earnings guidance for the half year ending September 30, 2014 and full year ending March 31, 2015. For the half year, the company forecasts net income of JPY 300 million or JPY 6.15 net income per share on net sales of JPY 26,800 million. The company forecasts operating and ordinary income of JPY 400 million and JPY 500 million respectively. For the full year, the company forecasts net income of JPY 800 million or JPY 16.41 net income per share on net sales of JPY 56,000 million. The company forecasts operating and ordinary income of JPY 1,200 million and JPY 1,400 million respectively.

JMS Co., Ltd. to Report Fiscal Year 2014 Results on May 08, 2014

JMS Co., Ltd. announced that they will report fiscal year 2014 results on May 08, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7702:JP ¥296.00 JPY -1.00

7702 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $76.87 USD +0.76
Fresenius Medical Care AG & Co KGaA €49.82 EUR +0.035
Nipro Corp ¥886.00 JPY -2.00
NxStage Medical Inc $13.56 USD +0.02
View Industry Companies

Industry Analysis


Industry Average

Valuation 7702 Industry Range
Price/Earnings 70.3x
Price/Sales 0.3x
Price/Book 0.5x
Price/Cash Flow 24.0x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JMS CO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at